Fresenius Medical Care AG (FMCQF)
OTCMKTS · Delayed Price · Currency is USD
51.06
-1.09 (-2.10%)
At close: Jul 29, 2025

Fresenius Medical Care AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
14,62313,41512,3119,58619,04024,433
Upgrade
Market Cap Growth
49.11%8.96%28.43%-49.65%-22.07%10.67%
Upgrade
Enterprise Value
26,78724,82926,51424,92833,69039,866
Upgrade
Last Close Price
51.0544.0940.2930.9662.1879.58
Upgrade
PE Ratio
18.9724.0922.3213.3217.2717.15
Upgrade
PS Ratio
0.640.670.570.460.951.12
Upgrade
PB Ratio
0.870.820.750.581.201.62
Upgrade
P/FCF Ratio
6.087.685.736.2110.246.28
Upgrade
P/OCF Ratio
4.525.434.244.146.734.72
Upgrade
EV/Sales Ratio
1.171.241.231.201.681.83
Upgrade
EV/EBITDA Ratio
7.1410.2210.089.2910.599.99
Upgrade
EV/EBIT Ratio
13.0915.5815.7415.1715.5613.71
Upgrade
EV/FCF Ratio
11.1414.2212.3416.1618.1210.25
Upgrade
Debt / Equity Ratio
0.770.700.820.860.951.00
Upgrade
Debt / EBITDA Ratio
3.643.643.924.063.823.12
Upgrade
Debt / FCF Ratio
5.396.526.219.158.153.89
Upgrade
Asset Turnover
0.600.570.560.550.530.55
Upgrade
Inventory Turnover
6.966.876.496.696.536.93
Upgrade
Quick Ratio
0.870.910.910.850.760.80
Upgrade
Current Ratio
1.441.401.421.271.101.20
Upgrade
Return on Equity (ROE)
5.72%4.84%4.84%6.08%9.27%11.24%
Upgrade
Return on Assets (ROA)
3.03%2.85%2.73%2.74%3.60%4.60%
Upgrade
Return on Capital (ROIC)
3.77%3.58%3.43%3.44%4.58%5.74%
Upgrade
Return on Capital Employed (ROCE)
6.20%5.50%5.50%5.30%7.00%9.30%
Upgrade
Earnings Yield
5.27%4.15%4.48%7.51%5.79%5.83%
Upgrade
FCF Yield
16.45%13.02%17.46%16.09%9.77%15.93%
Upgrade
Dividend Yield
3.18%3.38%3.26%3.87%2.47%2.06%
Upgrade
Payout Ratio
64.37%64.91%65.86%58.74%40.49%30.16%
Upgrade
Buyback Yield / Dilution
---0.06%-0.06%0.41%2.80%
Upgrade
Total Shareholder Return
3.18%3.38%3.21%3.81%2.88%4.86%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.